163 related articles for article (PubMed ID: 21631153)
1. Residual undifferentiated cells during differentiation of induced pluripotent stem cells in vitro and in vivo.
Fu W; Wang SJ; Zhou GD; Liu W; Cao Y; Zhang WJ
Stem Cells Dev; 2012 Mar; 21(4):521-9. PubMed ID: 21631153
[TBL] [Abstract][Full Text] [Related]
2. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells.
Kao CL; Tai LK; Chiou SH; Chen YJ; Lee KH; Chou SJ; Chang YL; Chang CM; Chen SJ; Ku HH; Li HY
Stem Cells Dev; 2010 Feb; 19(2):247-58. PubMed ID: 19656070
[TBL] [Abstract][Full Text] [Related]
4. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
Zhou W; Freed CR
Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
[TBL] [Abstract][Full Text] [Related]
6. Morphological Analysis of Live Undifferentiated Cells Derived from Induced Pluripotent Stem Cells.
Osawa Y; Miyamoto T; Ohno S; Ohno E
Stem Cells Dev; 2018 Jan; 27(1):1-9. PubMed ID: 28978257
[TBL] [Abstract][Full Text] [Related]
7. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency.
Menendez S; Camus S; Herreria A; Paramonov I; Morera LB; Collado M; Pekarik V; Maceda I; Edel M; Consiglio A; Sanchez A; Li H; Serrano M; Belmonte JC
Aging Cell; 2012 Feb; 11(1):41-50. PubMed ID: 21981310
[TBL] [Abstract][Full Text] [Related]
8. Prospects for pluripotent stem cell therapies: into the clinic and back to the bench.
Grabel L
J Cell Biochem; 2012 Feb; 113(2):381-7. PubMed ID: 21928325
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.
Chang YL; Chen SJ; Kao CL; Hung SC; Ding DC; Yu CC; Chen YJ; Ku HH; Lin CP; Lee KH; Chen YC; Wang JJ; Hsu CC; Chen LK; Li HY; Chiou SH
Cell Transplant; 2012; 21(1):313-32. PubMed ID: 21669041
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium.
Zhang L; Pan Y; Qin G; Chen L; Chatterjee TK; Weintraub NL; Tang Y
Cell Cycle; 2014; 13(5):762-71. PubMed ID: 24394703
[TBL] [Abstract][Full Text] [Related]
11. [Regeneration of the central nervous system using iPS cell-technologies].
Okano H
Rinsho Shinkeigaku; 2009 Nov; 49(11):825-6. PubMed ID: 20030221
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenic development of induced pluripotent stem cells in ischemic mouse brain.
Yamashita T; Kawai H; Tian F; Ohta Y; Abe K
Cell Transplant; 2011; 20(6):883-91. PubMed ID: 21054935
[TBL] [Abstract][Full Text] [Related]
13. High efficiency of reprogramming CD34⁺ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
Liu T; Zou G; Gao Y; Zhao X; Wang H; Huang Q; Jiang L; Guo L; Cheng W
Stem Cells Dev; 2012 Aug; 21(12):2322-32. PubMed ID: 22264161
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
de Lázaro I; Yilmazer A; Kostarelos K
J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem-induced cells show better constitutive heterochromatin remodeling and developmental potential after nuclear transfer than their parental cells.
Liu Z; Wan H; Wang E; Zhao X; Ding C; Zhou S; Li T; Shuai L; Feng C; Yu Y; Zhou Q; Beaujean N
Stem Cells Dev; 2012 Nov; 21(16):3001-9. PubMed ID: 22657835
[TBL] [Abstract][Full Text] [Related]
16. Neural stem cells differentiated from iPS cells spontaneously regain pluripotency.
Choi HW; Kim JS; Choi S; Hong YJ; Kim MJ; Seo HG; Do JT
Stem Cells; 2014 Oct; 32(10):2596-604. PubMed ID: 24898298
[TBL] [Abstract][Full Text] [Related]
17. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
Pan G; Wang T; Yao H; Pei D
Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
[TBL] [Abstract][Full Text] [Related]
18. iPS cells: a source of cardiac regeneration.
Yoshida Y; Yamanaka S
J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of mouse induced pluripotent stem cells into corneal epithelial-like cells.
Yu D; Chen M; Sun X; Ge J
Cell Biol Int; 2013 Jan; 37(1):87-94. PubMed ID: 23339091
[TBL] [Abstract][Full Text] [Related]
20. Genome editing in induced pluripotent stem cells.
Cheng LT; Sun LT; Tada T
Genes Cells; 2012 Jun; 17(6):431-8. PubMed ID: 22487259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
